Regulus Therapeutics reported $17K in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
AstraZeneca AZN:LN USD 387M 0
Astrazeneca AZN:US USD 387M 0
Biogen BIIB:US USD 100K 0
Celldex Therapeutics CLDX:US USD 47K 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Intercept Pharmaceuticals ICPT:US USD 41K 11K
IONIS PHARMACEUT IONS:US USD 142K 0
Lexicon Pharmaceuticals LXRX:US USD 189K 39K
Omeros OMER:US USD 627K 0
Regulus Therapeutics RGLS:US USD 17K 2K
Sangamo Biosciences SGMO:US USD 1.62M 85K
Spectrum Pharmaceuticals SPPI:US USD 203K 18K
Takeda 4502:JP JPY 1.68T 53M
Vital Therapies VTL:US USD 3K 0
YTE INCY:US USD 222K 0